ASCO Annual Meeting

Rybrevant Combo Improves Lung Cancer Outcomes After Tagrisso Failure

June 16th 2025, 7:00pm

Article

Rybrevant plus chemotherapy improved response and delayed disease progression for patients with EGFR-mutated non–small cell lung cancer after Tagrisso.

Explaining Brain Cancer and Metastases Updates for Patients

June 16th 2025, 4:11pm

Article

The 2025 ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

Delving Into Brain Cancer Treatment Takeaways Following ASCO 2025

June 16th 2025, 1:00pm

Video

The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs. Joshua K. Sabari and Manmeet Singh Ahluwalia.

Breaking Down the VERIFY Trial for Patients With Polycythemia Vera

June 13th 2025, 8:00pm

Video

Dr. Aaron Gerds breaks down the outcomes of the phase 3 VERIFY trial, investigating rusfertide, for patients with polycythemia vera, a type of blood cancer.

Updates in Shared Decision-Making in Lung Cancer Following ASCO 2025

June 13th 2025, 4:00pm

Article

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert oncologists.

What Should Patients With Lung Cancer Know After ASCO 2025?

June 13th 2025, 1:16pm

Video

Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.

Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025

June 12th 2025, 8:00pm

Video

Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.

What Patients With Genitourinary Cancers Need to Know After ASCO 2025

June 12th 2025, 4:00pm

Article

Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

What Patients With Genitourinary Cancers Should Know After ASCO 2025

June 11th 2025, 8:00pm

Video

Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology

Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera

June 11th 2025, 4:30pm

Article

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with polycythemia vera.